Minneapolis VAMC
Minneapolis, Minnesota 55417
1 studies enrolling now · 16 studies all time
What they study most
Arthritis, Body Weight, Cardiovascular Diseases, Chronic Diseases, Chronic Obstructive Pulmonary Disease, Chronic Pain, Clostridium Infections, Coronary Artery Disease, Coronary Disease, Critical Limb Ischemia, Diabetes Mellitus, Diarrhea
Studies at this site
- Reaching Rural Veterans: Applying Mind-Body Skills for Pain Using a Whole Health Telehealth Intervention - UH3 — Recruiting now
- Reaching Rural Veterans: Applying Mind-Body Skills for Pain Using a Whole Health Telehealth Intervention - UG3 Pilot Study — Completed
- International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
- Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
- Comparison of Mobile-Bearing and Fixed-Bearing All-Polyethylene Tibia Total Knee Designs — Stopped early
- Comparison of a Metal Backed Fixed-Bearing Tibial Baseplate and an All-Polyethylene Tibia in Total Knee Arthroplasty — Stopped early
- A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) — Completed
- Dissemination of a Weight Management Program Among US Veterans — Completed
- DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
- DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early
- Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes — Completed
- Longitudinal Care: Smoking Reduction to Aid Cessation — Completed
- SPIROCOR Coronary Outcome by Respiratory Stress Examination — Stopped early
- Veterans Integrated Service Network (VISN) 23 Lung Disease Self Management/Case Management Program — Completed
- Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain — Status unconfirmed
- Intra-articularInjection of Botulinum Toxin Type — Status unconfirmed